Enbrel 50 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQ4X2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,735
Award facts
- Contract value 100% obligated
- $37,735.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $37,735.46 by the Defense Logistics Agency on September 27, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price order is for Enbrel 50 mg/mL syringes, a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. The delivery order was issued without a set-aside designation, demonstrating AmerisourceBergen's continued ability to compete successfully for federal medical procurement requirements through open competition.
This delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQ4X2?
SPE2DB25FQ4X2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FQ4X2 worth?
The government has obligated $37,735 on SPE2DB25FQ4X2.
Is contract SPE2DB25FQ4X2 an order under another contract?
Yes. SPE2DB25FQ4X2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ4X2 competed?
The extent of competition for SPE2DB25FQ4X2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award